BIO Asia–Taiwan 2022 亞洲生技大會

BIO Asia–Taiwan 2022 亞洲生技大會

TEACHER

Tracy Humphries

Session 5 – New Modalities to Cure

Date:27 July (Wednesday)
Time:  15:40 – 17:10 (GMT+8)

Tracy Humphries

mRNA Segment Marketing Manager
Cytiva

.​

Tracy is the Global Segment Marketing Leader for nucleic acid-based therapeutics, such as mRNA, for Cytiva. She is accountable for supporting total value total value proposition and marketing activities aligned to market needs and the strategic roadmap. A biologist, with a B.Sc. from Portsmouth University and an MBA from Cranfield University, Tracy has over with over twenty years of experience in life science, marketing and sales across varied market and industry segments. 

Speech title & Synopsis

Innovation insights: An analysis of the evolving landscape of nucleic acid-based therapeutics

In recent years we have seen rapid evolution of nucleic acid-based therapeutics and vaccines. Is this evolution leading to the formation of a new technology toolbox? Can this toolbox leverage desired characteristics across a range of molecule types, based on therapeutic need? How do we consider the implications of modalities that stretch from truly personalized medicines through to global vaccine initiatives? In this presentation we will review current scientific research and analyze how this impacts upon the industrialization of flexible manufacturing.